Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a

Jianing Zhang1, Ji Ma2, Ying Li3

  • 1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Cancer Biology & Therapy
|September 19, 2024
PubMed

Insights

This study reveals that chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) can originate from the same B cell precursor. Whole-genome sequencing clarifies their clonal relationship and distinct differentiation pathways.

Area of Science:

  • Hematology
  • Genomics
  • Oncology

Background:

  • Chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are B cell malignancies.
  • The clonal relationship between CLL and MM is often unclear, hindering understanding of their pathogenesis.

Purpose of the Study:

  • To investigate the clonal relationship between synchronous CLL and MM in a rare clinical case.
  • To elucidate the B cell differentiation pathways involved in the development of both malignancies.

Main Methods:

  • Whole-genome sequencing (WGS) of malignant lymph node (LN) and bone marrow (BM) tissues.
  • Analysis of single nucleotide variants (SNVs), significantly mutated genes (SMGs), and copy number variations (CNVs).
  • Assessment of B cell receptor (BCR) IGH rearrangement and light-chain expression.

Main Results:

  • High consistency in SNVs, SMGs, and CNVs between CLL and MM samples.
  • Distinct BCR IGH rearrangement features and light-chain expression patterns observed.
  • Evidence suggests a common origin from hematopoietic stem cells/progenitors.

Conclusions:

  • CLL and MM in this patient originated from the same progenitor cell.
  • Oncogenic mutations occurred at different B cell differentiation stages.
  • WGS is a valuable tool for exploring malignant B cell genesis.